These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 23088210)
1. NADPH oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia. Abais JM; Zhang C; Xia M; Liu Q; Gehr TW; Boini KM; Li PL Antioxid Redox Signal; 2013 May; 18(13):1537-48. PubMed ID: 23088210 [TBL] [Abstract][Full Text] [Related]
2. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Zhang C; Boini KM; Xia M; Abais JM; Li X; Liu Q; Li PL Hypertension; 2012 Jul; 60(1):154-62. PubMed ID: 22647887 [TBL] [Abstract][Full Text] [Related]
3. Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia. Abais JM; Xia M; Li G; Gehr TW; Boini KM; Li PL Free Radic Biol Med; 2014 Feb; 67():211-20. PubMed ID: 24140862 [TBL] [Abstract][Full Text] [Related]
4. Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia. Abais JM; Xia M; Li G; Chen Y; Conley SM; Gehr TWB; Boini KM; Li PL J Biol Chem; 2014 Sep; 289(39):27159-27168. PubMed ID: 25138219 [TBL] [Abstract][Full Text] [Related]
5. Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia. Conley SM; Abais-Battad JM; Yuan X; Zhang Q; Boini KM; Li PL Free Radic Biol Med; 2017 May; 106():236-244. PubMed ID: 28193546 [TBL] [Abstract][Full Text] [Related]
6. Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia. Zhang C; Xia M; Boini KM; Li CX; Abais JM; Li XX; Laperle LA; Li PL Pflugers Arch; 2011 Sep; 462(3):455-67. PubMed ID: 21647593 [TBL] [Abstract][Full Text] [Related]
7. Redox signaling via lipid raft clustering in homocysteine-induced injury of podocytes. Zhang C; Hu JJ; Xia M; Boini KM; Brimson C; Li PL Biochim Biophys Acta; 2010 Apr; 1803(4):482-91. PubMed ID: 20036696 [TBL] [Abstract][Full Text] [Related]
8. NADPH oxidase-induced NALP3 inflammasome activation is driven by thioredoxin-interacting protein which contributes to podocyte injury in hyperglycemia. Gao P; He FF; Tang H; Lei CT; Chen S; Meng XF; Su H; Zhang C J Diabetes Res; 2015; 2015():504761. PubMed ID: 25834832 [TBL] [Abstract][Full Text] [Related]
9. Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes. Li G; Xia M; Abais JM; Boini K; Li PL; Ritter JK J Pharmacol Exp Ther; 2016 Jul; 358(1):61-70. PubMed ID: 27189966 [TBL] [Abstract][Full Text] [Related]
10. Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation. Zhang Q; Conley SM; Li G; Yuan X; Li PL Kidney Blood Press Res; 2019; 44(4):513-532. PubMed ID: 31266025 [TBL] [Abstract][Full Text] [Related]
11. NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury. Li G; Chen Z; Bhat OM; Zhang Q; Abais-Battad JM; Conley SM; Ritter JK; Li PL J Lipid Res; 2017 Jun; 58(6):1080-1090. PubMed ID: 28404641 [TBL] [Abstract][Full Text] [Related]
12. Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene. Zhang C; Hu JJ; Xia M; Boini KM; Brimson CA; Laperle LA; Li PL Free Radic Biol Med; 2010 Apr; 48(8):1109-17. PubMed ID: 20116427 [TBL] [Abstract][Full Text] [Related]
13. Podocyte-specific silencing of acid sphingomyelinase gene to abrogate hyperhomocysteinemia-induced NLRP3 inflammasome activation and glomerular inflammation. Huang D; Kidd JM; Zou Y; Wu X; Li N; Gehr TWB; Li PL; Li G Am J Physiol Renal Physiol; 2024 Jun; 326(6):F988-F1003. PubMed ID: 38634138 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of hyperhomocysteinemia-induced inflammasome activation and glomerular sclerosis by NLRP3 gene deletion. Xia M; Conley SM; Li G; Li PL; Boini KM Cell Physiol Biochem; 2014; 34(3):829-41. PubMed ID: 25171193 [TBL] [Abstract][Full Text] [Related]
15. Activation of inflammasomes in podocyte injury of mice on the high fat diet: Effects of ASC gene deletion and silencing. Boini KM; Xia M; Abais JM; Li G; Pitzer AL; Gehr TW; Zhang Y; Li PL Biochim Biophys Acta; 2014 May; 1843(5):836-45. PubMed ID: 24508291 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of TLR4 attenuates high glucose-induced podocyte injury via the NALP3/ASC/Caspase-1 signaling pathway. Liu Y; Xu Z; Ma F; Jia Y; Wang G Biomed Pharmacother; 2018 Nov; 107():1393-1401. PubMed ID: 30257355 [TBL] [Abstract][Full Text] [Related]
17. Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury. Li C; Xia M; Abais JM; Liu X; Li N; Boini KM; Li PL Naunyn Schmiedebergs Arch Pharmacol; 2013 Jun; 386(6):551-61. PubMed ID: 23529346 [TBL] [Abstract][Full Text] [Related]
18. Contribution of membrane raft redox signalling to visfatin-induced inflammasome activation and podocyte injury. Koka S; Surineni S; Singh GB; Boini KM Aging (Albany NY); 2023 Nov; 15(22):12738-12748. PubMed ID: 38032896 [TBL] [Abstract][Full Text] [Related]
19. Reversal by growth hormone of homocysteine-induced epithelial-to-mesenchymal transition through membrane raft-redox signaling in podocytes. Li CX; Xia M; Han WQ; Li XX; Zhang C; Boini KM; Liu XC; Li PL Cell Physiol Biochem; 2011; 27(6):691-702. PubMed ID: 21691087 [TBL] [Abstract][Full Text] [Related]
20. Formation of lipid raft redox signalling platforms in glomerular endothelial cells: an early event of homocysteine-induced glomerular injury. Yi F; Jin S; Zhang F; Xia M; Bao JX; Hu J; Poklis JL; Li PL J Cell Mol Med; 2009 Sep; 13(9B):3303-14. PubMed ID: 20196779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]